Concord Drugs (BOM:538965) has received purchase orders worth approximately 147.1 million from various entities, including Tamil Nadu Medical Services Corp., Directorate General of Health Services, and Telangana State Medical Services & Infrastructure Development Corp. and other entities, according to an Indian bourse filing on Tuesday.
The orders, covering supply of pharmaceutical products over the next 45 to 60 days, exceed the company's materiality threshold, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments